Impact of surfactants and other body fluids on in vitro activity of a novel ß-lactamase inhibitor enmetazobactam in combination with cefepime against clinical isolates of Klebsiella pneumoniae.

Nussbaumer-Pröll, Alina; Eberl, Sabine; Belley, Adam; Knechtle, Philipp; Huband, Michael D; Huynh, Holly K; Zeitlinger, Markus

Nussbaumer-Pröll, Alina; Eberl, Sabine; Belley, Adam; Knechtle, Philipp; Huband, Michael D; Huynh, Holly K; Zeitlinger, Markus.

Afiliação

Nussbaumer-Pröll A; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Eberl S; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Belley A; Allecra Therapeutics SAS, Saint-Louis, France.
Knechtle P; Allecra Therapeutics SAS, Saint-Louis, France.
Huband MD; JMI Laboratories, Iowa City, IA, USA.
Huynh HK; JMI Laboratories, Iowa City, IA, USA.
Zeitlinger M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria. markus.zeitlinger@meduniwien.ac.at.

J Antibiot (Tokyo) ; 76(3): 183-189, 2023 03.

Article em En | MEDLINE | ID: mdl-36690707

Assuntos

Líquidos Corporais; Daptomicina; Humanos; Cefepima/farmacologia; Inibidores de beta-Lactamases; Klebsiella pneumoniae; Cefalosporinas/farmacologia; Tensoativos; Staphylococcus aureus; Antibacterianos/farmacologia; Monobactamas; Escherichia coli; Testes de Sensibilidade Microbiana; beta-Lactamases

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Líquidos Corporais / Daptomicina Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google